BSE filing, NSE: NIYATILEAS. Summary written from the filing by ALFA Finder's alert engine.
Veerhealth Care Ltd: key numbers
- Share price
- ₹48.90
- Market cap
- ₹97.79 Cr
- Revenue (annual)
- ₹32.48 Cr
- Net profit (annual)
- ₹0.54 Cr
- P/E (TTM)
- 63.9×Sector 46.5×
- Promoter holding
- 31.88%-0.03% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Veerhealth Care Ltd
All →Veerhealth Care Earnings Call Transcript: Key Takeaways
Veerhealth is aggressively scaling through contract manufacturing for top FMCG players. The 3x revenue target for FY27 hinges on successful capacity expansion and international hotel supply orders.
- Call
- Guides 200% growth
Veerhealth Care Other Announcement
Veerhealth Care Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Veerhealth Care Bags ₹4.55 Cr Order from FMCG company
Veerhealth Care Ltd has received an order worth Rs. 4.55 Crore from a leading FMCG company for the supply of skincare products.
- Value
- ₹4.55 Cr
- From
- FMCG company
- Execution
- 45 Days
Veerhealth Care Annual General Meeting
Veerhealth Care Ltd issued a corrigendum to its 34th AGM notice, revising the scheduled meeting time to 04:00 P.M. on 23rd September 2026.
Veerhealth Care Bags ₹0.1 Cr Order
Veerhealth Care Ltd received its first purchase order for oral care products worth ₹0.10 Crore. The contract is to be executed within 45 days.
- Value
- ₹0.10 Cr
- Execution
- 45 days
Veerhealth Care Bags ₹4.36 Cr Order from one of India's Leading FMCG company
Veerhealth Care Ltd secured a monthly repeat order worth ₹4.36 Crore from a leading FMCG company for skin care products. The order will be executed within 45 days.
- Value
- ₹4.36 Cr
- From
- one of India's Leading FMCG company
- Execution
- 45 days
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.